MedTrace Logo

Adductor Canal Block

NCT04513145 · Status: TERMINATED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 93

Last updated 2026-04-06

No results posted yet for this study

Summary

The investigators aim to investigate whether the addition of a surgeon-administered adductor canal blockade to a multimodal periarticular injection cocktail provides additional pain relief for patients undergoing total knee arthroplasty. This study will help identify the effectiveness of surgeon-administered adductor canal blockade in perioperative pain control for patients undergoing total knee arthroplasty

Conditions

Interventions

DRUG

Ropivacaine injection

Ropivacaine is a local anesthetic that is FDA approved for local anesthetic nerve block.

DRUG

Saline Injection

Saline will be used as a placebo injection

PROCEDURE

Total Knee Arthroplasty

All subjects participating in this study will undergo primary total knee arthroplasty

Sponsors & Collaborators

  • Towson Orthopaedic Associates

    collaborator OTHER

  • OrthoCarolina Research Institute, Inc.

    lead OTHER

Principal Investigators

  • Bryan D Springer, MD · OrthoCarolina Research Institute, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-10-09
Primary Completion
2024-12-31
Completion
2025-05-23
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04513145 on ClinicalTrials.gov